Stock Events

Stock Events

Intuitive Surgical

$443.76

973

+$9.26+2.13% Friday 20:00

Statistics

Day High

445.05

Day Low

433.43

52W High

448.1

52W Low

254.85

Volume

1,114,218

Avg. Volume

1,477,873

Mkt Cap

157.4B

P/E Ratio

80.1

Dividend Yield

-

Dividend

-

Upcoming

Earnings

18JulConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

Next

1.2

1.31

1.43

1.54

Expected EPS

1.54069

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ISRG. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Medtronic competes with Intuitive Surgical in the robotic-assisted surgery space, particularly with its Hugo robotic-assisted surgery system.

Johnson & Johnson

Johnson & Johnson, through its subsidiary Auris Health, Inc., offers the Monarch Platform, a robotic technology for diagnostic and therapeutic procedures in the lung, competing in the robotic surgical space.

Smith & Nephew offers the NAVIO Surgical System, a next-generation handheld robotics platform, and the CORI Surgical System, competing in the orthopedic robotic surgery market.

Zimmer Biomet Holdings, Inc. competes with its ROSA Robotics platform, which includes solutions for knee, spine, and brain surgeries.

Stryker Corporation competes with its Mako Robotic-Arm Assisted Surgery system, offering precision in orthopedic surgeries, directly competing in the robotic surgery market.

Globus Medical, Inc. competes with its ExcelsiusGPS, a robotic navigation technology for spine surgery, entering the robotic surgery market.

Intuitive Surgical

Intuitive Surgical directly competes with itself through continuous innovation and development of new systems and enhancements to its da Vinci surgical systems.

Baxter International

Baxter International Inc. competes in the broader surgical products and services market, offering a range of products that can be seen as complementary or competitive to robotic surgery solutions.

Boston Scientific

Boston Scientific Corporation competes in the medical devices market with a focus on minimally invasive surgeries, offering products that could compete with robotic surgery systems in certain applications.

Analyst Ratings

430.14$Average Price Target

The highest estimate is $500.

From 14 ratings within the last 6 months. This is not an investment recommendation.

Buy

79%

Hold

21%

Sell

0%

About

Health Technology

Medical Specialties

Manufacturing

Surgical and Medical Instrument Manufacturing

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Show more...

CEO

Gary Guthart

Employees

13676

Country

US

ISIN

US46120E6023

WKN

000888024

Listings